A-4

Diagnostic Use (Allergenic Extract)

For skin prick testing, a single drop of the 1:10 or 1:20 w/v extract is applied to the skin (usually the forearm or back), followed by a prick through the drop using a sterile lancet. Results are interpreted after 15–20 minutes. Intradermal testing involves the injection of 0.02 mL of a much more dilute solution (e.g., 1:1000 w/v) into the dermis.

Therapeutic Use (Flavanol/Methylxanthine Support)

While not standardized as a prescription drug for these purposes, clinical studies often utilize doses of 400 mg to 900 mg of cocoa flavanols daily, divided into two doses. For theobromine-specific effects, doses of 250 mg to 500 mg have been studied.

Diagnostic Use

Pediatric dosing for skin testing is similar to adult dosing (one drop of extract). However, healthcare providers must exercise extreme caution due to the higher risk of systemic reactions in highly sensitized children.

Therapeutic Use

Cocoa extracts for therapeutic purposes are generally not recommended for children under the age of 12 unless directed by a specialist. The stimulant effects of methylxanthines can cause disproportionate restlessness and tachycardia in pediatric patients.

Renal Impairment

Patients with severe renal impairment (CrCl < 30 mL/min) may experience reduced clearance of theobromine metabolites. While no specific dose reduction is mandated for diagnostic tests, chronic therapeutic use should be monitored closely for signs of methylxanthine toxicity.

Hepatic Impairment

Since cocoa alkaloids are metabolized by the liver (CYP1A2), patients with cirrhosis or significant hepatic dysfunction may have a prolonged half-life of theobromine. Doses should be spaced further apart to prevent accumulation.

Elderly Patients

Elderly patients are more sensitive to the cardiovascular and CNS stimulant effects of cocoa. Lower starting doses for therapeutic extracts are advised, with frequent monitoring of heart rate and blood pressure.

• For Diagnostic Testing: This is performed exclusively in a clinical setting. You do not 'take' this form yourself.
• For Oral Supplements: Cocoa extracts should be taken with water. While they can be taken with or without food, taking them with a small meal may reduce the risk of gastrointestinal upset.
• Time of Day: Due to the methylxanthine (caffeine-like) content, it is best to take cocoa extracts in the morning or early afternoon to avoid sleep disturbances.
• Storage: Store extracts and capsules in a cool, dry place (15°C to 30°C / 59°F to 86°F) away from direct sunlight.

If you miss a dose of a cocoa supplement, take it as soon as you remember. However, if it is nearly time for your next dose or late in the evening, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of heart palpitations and insomnia.

Signs of cocoa or methylxanthine overdose include:

• Severe tachycardia (rapid heart rate)
• Arrhythmias (irregular heartbeats)
• Persistent vomiting
• Tremors or seizures
• Extreme anxiety or agitation
• Profuse sweating

In the event of a suspected overdose, especially in children or pets (who are highly sensitive to theobromine), contact a Poison Control Center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on heart rate control and seizure prevention.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Most patients taking standard amounts of cocoa or undergoing diagnostic testing experience minimal issues. However, common reactions include:

• Gastrointestinal Upset: Nausea, bloating, or abdominal discomfort as the digestive system processes the tannins and fibers in the extract.
• Nervousness/Jitteriness: A feeling of 'caffeine-like' stimulation, which may include mild hand tremors or a sense of internal restlessness.
• Increased Urination: Theobromine and caffeine act as mild diuretics, increasing the frequency of trips to the bathroom.
• Sleep Disturbances: Difficulty falling asleep or staying asleep, particularly if taken within 6 hours of bedtime.

• Tachycardia: A noticeable increase in heart rate or 'thumping' in the chest (palpitations).
• Headaches: Some individuals may experience migraines or tension headaches triggered by the tyramine or methylxanthines in cocoa.
• Gastroesophageal Reflux (GERD): Cocoa can relax the lower esophageal sphincter, causing heartburn or acid reflux.
• Skin Reactions: Mild itching or a small rash at the site of diagnostic testing (if not a full positive reaction).

• Hypokalemia: In very high doses, methylxanthines can cause a shift of potassium into cells, resulting in low blood potassium levels.
• Severe Anxiety/Panic Attacks: In predisposed individuals, the stimulant effects can trigger acute anxiety.
• Cardiac Arrhythmias: Premature ventricular contractions (PVCs) or other rhythm disturbances.

> Warning: Stop taking Cocoa and call your doctor immediately if you experience any of these.

• Anaphylaxis: This is the most critical risk during diagnostic testing. Symptoms include swelling of the face, tongue, or throat; difficulty breathing; a rapid drop in blood pressure; and fainting.
• Chest Pain: Any pressure or pain in the chest, which could indicate cardiac stress.
• Seizures: High levels of methylxanthines can lower the seizure threshold.
• Severe Vomiting: Could indicate acute methylxanthine toxicity.

• Bone Density Concerns: Chronic, excessive intake of methylxanthines may interfere with calcium absorption, potentially impacting bone mineral density over many years if calcium intake is insufficient.
• Tolerance and Dependence: Regular use can lead to a mild physical dependence, where stopping the extract suddenly results in withdrawal headaches, fatigue, and irritability.
• Weight Changes: While some studies suggest cocoa helps with metabolism, the caloric content of certain preparations could lead to weight gain if not monitored.

No FDA black box warnings for Cocoa. However, the FDA requires that all allergenic extracts carry a general warning regarding the risk of severe systemic reactions, including anaphylaxis. These extracts must only be used by clinicians prepared to manage life-threatening allergic emergencies.

Report any unusual symptoms to your healthcare provider. If you notice a change in your heart rhythm or experience persistent dizziness, discontinue use and seek a medical evaluation.

Cocoa is generally recognized as safe (GRAS) for consumption, but its use as a concentrated clinical extract requires specific precautions. The primary concern is the potential for anaphylactic shock during diagnostic testing. Patients with a known history of severe asthma or unstable cardiovascular disease are at a higher risk for complications if a systemic reaction occurs.

As of 2026, there are no specific FDA black box warnings for Cocoa extracts. However, standardized and non-standardized allergenic extracts are governed by strict administration guidelines requiring the presence of emergency equipment (epinephrine, oxygen, airway management tools) during use.

• Allergic Reactions / Anaphylaxis Risk: Patients undergoing skin testing must be observed for at least 30 minutes post-procedure. A history of severe chocolate allergy is a significant red flag.
• Cardiovascular Sensitivity: Because Cocoa is a Central Nervous System Stimulant [EPC], it can exacerbate pre-existing arrhythmias, hypertension, or tachycardia. It should be used with caution in patients who have recently suffered a myocardial infarction (heart attack).
• Gastrointestinal Disorders: Cocoa may worsen symptoms of stomach ulcers or GERD due to its effect on gastric acid secretion and sphincter relaxation.
• Bleeding Risk: Due to its classification as an Anti-coagulant [EPC], Cocoa may slightly increase the risk of bruising or bleeding, especially when combined with other blood thinners.
• Anxiety and Psychiatric Disorders: The stimulant properties can worsen symptoms of generalized anxiety disorder (GAD) or bipolar disorder.

For patients using concentrated cocoa extracts for therapeutic purposes, the following may be monitored:

• Blood Pressure and Heart Rate: To ensure the stimulant effect is not causing cardiovascular strain.
• Blood Glucose: Cocoa may affect insulin sensitivity; diabetic patients should monitor their levels closely when starting or stopping cocoa extracts.
• Kidney Function: Periodic BUN and Creatinine tests for those using it as a Calculi Dissolution Agent [EPC] over the long term.

For most patients, Cocoa does not impair the ability to drive. However, if the extract causes significant 'jitters,' tremors, or anxiety, patients should avoid operating heavy machinery until they understand how the substance affects them.

Alcohol should be used with caution. Both alcohol and cocoa can increase heart rate, and cocoa's stimulant effect may mask the depressive effects of alcohol, leading to 'wide-awake' intoxication and increased risk-taking behavior.

If you have been taking high doses of cocoa extract daily, do not stop abruptly. Gradual tapering over 1–2 weeks is recommended to avoid 'caffeine-type' withdrawal symptoms such as severe headaches, lethargy, and depressed mood.

> Important: Discuss all your medical conditions with your healthcare provider before starting Cocoa.

• MAO Inhibitors (e.g., Phenelzine, Selegiline): Combining Cocoa with Monoamine Oxidase Inhibitors can lead to a dangerous rise in blood pressure (hypertensive crisis) due to the synergistic effect on catecholamines and the presence of tyramine in some cocoa extracts.

• Clozapine (Clozaril): Cocoa (specifically the caffeine/methylxanthine component) can increase clozapine blood levels by inhibiting its metabolism via CYP1A2, potentially leading to clozapine toxicity (seizures, sedation).
• Adenosine (Adenocard): Cocoa acts as an adenosine receptor antagonist. It can block the effects of adenosine used during cardiac stress tests or for treating supraventricular tachycardia, rendering the medication ineffective.
• Theophylline: As a fellow methylxanthine, theophylline's effects and toxicity are additive with Cocoa. This can lead to nausea, palpitations, and seizures.

• Anticoagulants/Antiplatelets (e.g., Warfarin, Aspirin, Clopidogrel): Because Cocoa has Anti-coagulant [EPC] properties, it may enhance the effect of these drugs, increasing the risk of bleeding.
• Lithium: Methylxanthines can increase the renal excretion of lithium, potentially lowering its plasma concentration and reducing its psychiatric efficacy.
• Quinolone Antibiotics (e.g., Ciprofloxacin): These drugs can inhibit the metabolism of the methylxanthines in cocoa, leading to increased stimulant side effects.

• Caffeine/Coffee/Tea: Using Cocoa alongside other caffeinated products significantly increases the risk of tachycardia, insomnia, and tremors.
• Dairy: Some studies suggest that milk proteins may bind to cocoa flavanols, potentially reducing their absorption and antioxidant efficacy.
• High-Fat Meals: May delay the Tmax of theobromine but generally does not reduce the total amount absorbed.

• Ephedra/Bitter Orange: These stimulants combined with Cocoa can cause dangerous increases in heart rate and blood pressure.
• St. John's Wort: May induce CYP1A2, potentially reducing the levels of cocoa's active alkaloids.
• Garlic/Gingko/Ginseng: May further increase the bleeding risk when combined with cocoa's anti-platelet effects.

• Urinary Catecholamines: Cocoa can cause false-positive elevations in tests for vanillylmandelic acid (VMA) and other catecholamine metabolites used to diagnose certain tumors (pheochromocytoma).
• Dipyridamole Thallium Imaging: Cocoa must be avoided for 24 hours prior to this test as it interferes with the pharmacological vasodilation required for the scan.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Severe Hypersensitivity: Cocoa must NEVER be used in patients with a known history of anaphylaxis or severe systemic reactions to chocolate or any component of the extract.
• Acute Myocardial Infarction: Due to its stimulant properties and potential to increase myocardial oxygen demand, it is contraindicated during the acute phase of a heart attack.
• Severe Tachyarrhythmias: Patients with uncontrolled rapid heart rhythms (such as atrial fibrillation with rapid ventricular response) should not use concentrated cocoa extracts.

• Uncontrolled Hypertension: The mild pressor effect of methylxanthines may make blood pressure management more difficult.
• Active Peptic Ulcer Disease: Cocoa stimulates gastric acid secretion, which can delay the healing of ulcers or cause acute pain.
• Anxiety Disorders: Patients with panic disorder may find that cocoa extracts trigger or worsen their symptoms.
• Pregnancy (High Doses): While moderate food intake is safe, high-dose clinical extracts are generally avoided due to the stimulant load on the fetus.

Patients who are allergic to Kola nut or other members of the Malvaceae family may exhibit cross-reactivity to Cocoa extracts. There is also a known cross-sensitivity with certain fungal allergens, which is why Cocoa is sometimes categorized as a Non-Standardized Fungal Allergenic Extract [EPC] in specific diagnostic contexts where mold contamination of the raw bean is a factor.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Cocoa.

FDA Pregnancy Category: Not formally assigned (Category C equivalent).

Cocoa contains theobromine and caffeine, both of which cross the placenta. High intake of methylxanthines (exceeding 200-300 mg daily) has been associated with an increased risk of low birth weight and, in some studies, pregnancy loss. While the flavanols in cocoa may support blood pressure in late pregnancy (preeclampsia prevention), this must only be done under strict medical supervision. Clinical extracts for diagnostic testing should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Theobromine and caffeine pass into breast milk. While generally safe in moderate amounts, concentrated cocoa extracts may cause the nursing infant to become irritable, fussy, or have difficulty sleeping. The American Academy of Pediatrics (AAP) suggests monitoring the infant for these signs if the mother is consuming high levels of methylxanthines.

Cocoa is approved as an allergenic extract for children of all ages for diagnostic purposes. However, its use as a therapeutic stimulant or supplement is not recommended for children under 12. Children are more susceptible to the CNS effects of methylxanthines, which can manifest as hyperactivity or behavioral changes. Long-term effects on growth have not been established.

Clinical data suggest that elderly patients may have a reduced clearance of cocoa alkaloids. Furthermore, the elderly are at a higher risk for cocoa-induced arrhythmias and sleep disturbances. Caution is advised in patients over 65, particularly those with underlying heart disease or those taking multiple medications (polypharmacy) that may interact with CYP1A2.

In patients with a GFR below 30 mL/min, the metabolites of cocoa alkaloids can accumulate. While not typically requiring a dose adjustment for a one-time diagnostic test, chronic use should be approached with caution. Cocoa is not significantly cleared by hemodialysis.

Patients with Child-Pugh Class B or C hepatic impairment will likely have a significantly prolonged half-life for theobromine. Because the liver is the primary site of metabolism, these patients are at a much higher risk for toxicity from standard doses of cocoa extracts.

> Important: Special populations require individualized medical assessment.

Cocoa's primary pharmacological activity is driven by its methylxanthines (theobromine, caffeine) and polyphenols (flavanols).

1. 1Adenosine Antagonism: Theobromine and caffeine competitively bind to A1 and A2A adenosine receptors in the CNS and cardiac tissue. By blocking adenosine—which normally promotes sleep and vasodilation—cocoa induces alertness and vasoconstriction in certain vascular beds.
2. 2PDE Inhibition: Cocoa inhibits phosphodiesterase enzymes (primarily PDE3 and PDE4), preventing the breakdown of cAMP. This leads to bronchodilation and increased cardiac contractility.
3. 3Nitric Oxide Modulation: Cocoa flavanols stimulate the enzyme Nitric Oxide Synthase, increasing NO production, which relaxes vascular smooth muscle and improves endothelial function.

• Onset of Effect: CNS stimulation begins within 30–60 minutes. Vascular effects (vasodilation) may take 1–2 hours.
• Duration: The effects of theobromine can last for 6–10 hours due to its slow clearance.
• Tolerance: Frequent use leads to 'up-regulation' of adenosine receptors, meaning higher doses are required over time to achieve the same stimulant effect.

| Parameter | Value |

|---|---|

| Bioavailability | >90% (Methylxanthines) |

| Protein Binding | 15% - 20% |

| Half-life | 7 - 12 hours (Theobromine) |

| Tmax | 2 - 4 hours |

| Metabolism | Hepatic (CYP1A2, CYP2E1) |

| Excretion | Renal (90% as metabolites) |

• Molecular Formula: C7H8N4O2 (Theobromine)
• Molecular Weight: 180.16 g/mol
• Solubility: Slightly soluble in water; soluble in hot water and aqueous acids.
• Structure: A xanthine alkaloid with two methyl groups at positions 3 and 7.

Cocoa is classified as a Non-Standardized Food Allergenic Extract [EPC]. It is also functionally a Methylxanthine and a Central Nervous System Stimulant. It shares properties with other xanthines like theophylline and caffeine.